The vaping cessation pill, varenicline, has emerged as a promising solution for young adults looking to break free from nicotine addiction.Recent clinical trials have demonstrated its significant efficacy, revealing that participants aged 16 to 25 who used this FDA-approved medication were more than three times as successful in quitting vaping compared to those who received only behavioral support.